News

A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine.

The GW Cancer Center hosts a monthly breast cancer disparities work group to facilitate connections across the University between researchers, clinicians and members of the community, including survivors and caregivers.

WASHINGTON (Jan. 28, 2018) — A team from the George Washington University (GW) Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer. The goal of this nanoimmunotherapy combination is to increase the potency of immune...

Members of the George Washington University (GW) Cancer Center, including Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity, recently published several journal articles and patient-focused pieces highlighting the GW Cancer Center’s work in patient navigation and survivorship.

The George Washington University (GW) Cancer Center is pleased to announce that Vishal A. Patel MD, FAAD, FACMS , an accomplished Mohs/Dermatologic surgeon and cutaneous oncologist, has joined the GW Cancer Center. He will serve as the director of the recently established Cutaneous Oncology Program...

Cancer of the skin is by far the most common of all cancers with melanoma being the cause of the majority of skin cancer deaths. The incidence of melanoma continues to increase and it has become one of the most common forms of cancer in the United States, especially among young adult women ages 20-...

The George Washington University (GW) Cancer Center recently hosted Improving Care for Sexual and Gender Minorities: A Symposium for Health Care Professional Students and Faculty at the Elliott School of International Affairs.

Gazing at the iconic 19th-century Japanese woodcut known as “The Great Wave off Kanagawa,” one would hardly suspect it contains a key to a medical breakthrough. Yet the pigment in the artwork has opened a new perspective in the treatment of juvenile cancer.

Innumerable questions and concerns loom after a cancer diagnosis. Among them: Should I participate in a clinical trial, or should I stick with the standard of care? Here's an inside look at the clinical trials process.

A research team led by Catherine Bollard, PhD, associate center director for translational research and innovation, has developed a new therapeutic cancer treatment called TAA-T.

In June 2018, before a room full of oncology experts, Robert Siegel, MD ’77, associate center director for education, training, and network development at the GW Cancer Center, described a new treatment developed for patients suffering from oropharyngeal cancer.

The future of cancer research, in the opinion of Katherine Chiappinelli, PhD, of the GW School of Medicine and Health Sciences, revolves around combining immunotherapy with other treatments.

The George Washington University (GW) Cancer Center was pleased to participate in the 43rd Annual Marine Corps Marathon (MCM) on October 28, 2018. The event is one of the largest in the world with over 30,000 participants and brings together multiple organizations to raise funds for charitable...

Applications for the second cohort of the Together, Equitable, Accessible, Meaningful (TEAM) Training are now open! This no-cost training aims to support equitable, accessible and patient-centered cancer care. The training provides guidance, tools and resources to help individuals and organizations...

WASHINGTON (Oct. 31, 2018) – Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by the...

Associate Professor at the Milken Institute School of Public Health at GW and GW Cancer Center member Kim Robien, PhD, RD, CSO, FAND, received the Distinguished Practice Award from the Oncology Nutrition practice group of the Academy of Nutrition and Dietetics on October 21st at the annual Food and...

A host of representatives from throughout the George Washington University (GW) health care community joined GW Cancer Center leadership on Oct. 17 to cut the ribbon on a new multi-disciplinary cancer clinical space in the ground floor of the GW Medical Faculty Associates (GW MFA) Ambulatory Care...

More people in the United States die from lung cancer than any other type of cancer (Centers for Disease Control and Prevention (CDC), 2018). Lung Cancer Awareness Month in November is an annual opportunity to support lung cancer survivors, caregivers and families of those who have been diagnosed...

To commemorate Breast Cancer Awareness Month and celebrate the GW Cancer Center and GW Medical Faculty Associates’ Mammovan, the 7th Annual Blush Lunch was held at the Ritz-Carlton, West End in Washington, D.C. on October 17, 2018.

Adam Friedman, MD, is the senior author of a study on the efficacy of nanoparticles in therapies for triple-negative breast cancer.

Did you know that breast cancer in the United States is the most common cancer in women, except for skin cancers (CDC, 2018)? October is Breast Cancer Awareness Month, an important time to honor and support the 3.1 million breast cancer survivors in the United States (American Cancer Society, 2018...

WASHINGTON (Sept. 26, 2018) – Rong Li, PhD, will serve as chair of the Department of Biochemistry and Molecular Medicine at the George Washington University (GW) School of Medicine and Health Sciences. He will also serve as a professor in the department. "As an internationally recognized researcher...

Dr. Adam Friedman joins breast cancer survivor Mariam Said to discuss side effects of cancer treatment and how the Supportive Oncodermatology Clinic at the GW Cancer Center is giving patients hope and resources for relief.

The George Washington University (GW) Cancer Center recently co-hosted a workshop on Improving the Health of the LGBTQ+ Community: Advocating for Ourselves Together at Metropolitan Community Church in D.C. More than 60 researchers, students, community members and health care workers gathered to...

Norman Lee, PhD, is investigating the mechanism behind dysregulation splicing factor expression.